The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
Headline as filed by CNBC Business. PageNews does not write or rewrite headlines.
Coverage overview
One publisher, CNBC Business, has reported this so far, at 16:28 UTC on 6 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The publisher's own headline, summary and link is below.
Compiled by PageNews from the reports listed below. No publisher wrote this summary.
Original report
-
CNBC Business
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
Read on CNBC Business →